| Increased efficiency of hemodialysis with citrate dialysate: a prospective controlled study RJ Kossmann, A Gonzales, R Callan, S Ahmad Clinical Journal of the American Society of Nephrology 4 (9), 1459-1464, 2009 | 105 | 2009 |
| Real-world effectiveness of sucroferric oxyhydroxide in patients on chronic hemodialysis: a retrospective analysis of pharmacy data DW Coyne, LH Ficociello, V Parameswaran, L Anderson, S Vemula, ... Clinical Nephrology 88 (2), 59, 2017 | 52 | 2017 |
| Choosing home hemodialysis: a critical review of patient outcomes BW Miller, R Himmele, DA Sawin, J Kim, RJ Kossmann Blood purification 45 (1-3), 224-229, 2018 | 33 | 2018 |
| One-year historical cohort study of the phosphate binder sucroferric oxyhydroxide in patients on maintenance hemodialysis J Kendrick, V Parameswaran, LH Ficociello, NJ Ofsthun, S Davis, ... Journal of Renal Nutrition 29 (5), 428-437, 2019 | 31 | 2019 |
| Online measurement of hemodialysis adequacy using effective ionic dialysance of sodium—a review of its principles, applications, benefits, and risks S Aslam, SJ Saggi, M Salifu, RJ Kossmann Hemodialysis International 22 (4), 425-434, 2018 | 30 | 2018 |
| Real-world scenario improvements in serum phosphorus levels and pill burden in peritoneal dialysis patients treated with sucroferric oxyhydroxide K Kalantar-Zadeh, V Parameswaran, LH Ficociello, L Anderson, ... American journal of nephrology 47 (3), 153-161, 2018 | 26 | 2018 |
| Humoral response to mRNA versus an adenovirus vector-based SARS-CoV-2 vaccine in dialysis patients JG Mulhern, A Fadia, R Patel, LH Ficociello, J Willetts, IA Dahne-Steuber, ... Clinical Journal of the American Society of Nephrology 16 (11), 1720-1722, 2021 | 20 | 2021 |
| Machine learning for prediction of patients on hemodialysis with an undetected SARS-CoV-2 infection CK Monaghan, JW Larkin, S Chaudhuri, H Han, Y Jiao, KM Bermudez, ... Kidney360 2 (3), 456-468, 2021 | 16 | 2021 |
| Changes in serum albumin and other nutritional markers when using sucroferric oxyhydroxide as phosphate binder among hemodialysis patients: a historical cohort study K Kalantar-Zadeh, LH Ficociello, V Parameswaran, NV Athienites, ... BMC nephrology 20, 1-8, 2019 | 16 | 2019 |
| Sucroferric oxyhydroxide in maintenance hemodialysis: a retrospective, comparative cohort study DW Coyne, LH Ficociello, V Parameswaran, MM Rosen, C Mullon, ... Kidney medicine 2 (3), 307-316, 2020 | 15 | 2020 |
| Phosphates in medications: Impact on dialysis patients DA Sawin, L Ma, A Stennett, N Ofsthun, R Himmele, RJ Kossmann, ... Clinical Nephrology 93 (4), 163, 2020 | 11 | 2020 |
| Meeting the demand for renal replacement therapy during the COVID-19 pandemic: a manufacturer’s perspective MS Anger, C Mullon, LH Ficociello, D Thompson, MA Kraus, P Newcomb, ... Kidney360 2 (2), 350-354, 2021 | 9 | 2021 |
| From CKD to ESRD: a tale of two transitions RJ Kossmann Advances in Chronic Kidney Disease 18 (6), 439-442, 2011 | 9 | 2011 |
| Artificial intelligence for covid-19 risk classification in kidney disease: Can technology unmask an unseen disease? C Monaghan, JW Larkin, S Chaudhuri, H Han, Y Jiao, KM Bermudez, ... MedRxiv, 2020.06. 15.20131680, 2020 | 8 | 2020 |
| Clinical evaluation of a model for prediction of end-dialysis systemic ionized calcium concentration in citrate hemodialysis S Thijssen, RJ Kossmann, A Kruse, P Kotanko Blood Purification 35 (1-3), 133-138, 2013 | 7 | 2013 |
| Fifty-five percent heparin reduction is safe with citrate dialysate in chronic dialysis patients RJ Kossmann, R Callan, S Ahmed J Am Soc Nephrol 17, 109-110, 2006 | 7 | 2006 |
| Heparin reduction with citrate dialysate S Ahmad, R Callan, R Kossmann NEPHROLOGY DIALYSIS TRANSPLANTATION 21, 427-427, 2006 | 7 | 2006 |
| Safety of a novel dialyzer containing a fluorinated polyurethane surface-modifying macromolecule in patients with end-stage kidney disease JM Meyer, D Steer, LA Weber, AA Zeitone, M Thakuria, CH Ho, S Aslam, ... Blood Purification 50 (6), 959-967, 2021 | 6 | 2021 |
| Predictors of shorter-and longer-term mortality after COVID-19 presentation among dialysis patients: parallel use of machine learning models in Latin and North American countries AM Guinsburg, Y Jiao, MID Bessone, CK Monaghan, B Magalhães, ... BMC nephrology 23 (1), 340, 2022 | 4 | 2022 |
| Sucroferric oxyhydroxide as part of combination phosphate binder therapy among hemodialysis patients DA Molony, V Parameswaran, LH Ficociello, C Mullon, RJ Kossmann Kidney360 1 (4), 263-272, 2020 | 4 | 2020 |
Franklin W. Maddux, MD, FACPChief Medical Officer and Executive Vice President of Clinical and Scientific Affairs, FreseniusBestätigte E-Mail-Adresse bei fmc-na.com
